Biocon Ltd (BIOCON) Q4FY26 Management Mirror - Mar-2026 Qtr
Debt and Interest Costs
Management consistently prioritized debt reduction across quarters, guiding in the Mar'26 Qtr that net debt will hover between $1.1 billion and $1.2 billion subject to working capital, with all free cash flow directed toward debt paydown, while firmly reiterating the Sep'25 Qtr and Dec'25 Qtr expectations for annualized interest cost savings of approximately INR 3 billion (INR 700 million to 750 million quarterly) to fully materialize starting in FY27. [Status: Reaffirmed]
4 more themes on the ELITE plan.